KI-67 Antigen Expression Predicts Survival and Correlates with Histologic Subtype in the WHO Classification of Thymic Epithelial Tumors

We performed an immunohistochemical study with monoclonal antibodies to Ki-67 antigen and p53 protein on 45 cases of thymic epithelial tumors classified according to the recent World Health Organization (WHO) classification system to evaluate whether there is correlation between the expression of th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of surgical pathology 2004-10, Vol.12 (4), p.395-400
Hauptverfasser: Comin, Camilla E., Messerini, Luca, Novelli, Luca, Boddi, Vieri, Dini, Sergio
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 400
container_issue 4
container_start_page 395
container_title International journal of surgical pathology
container_volume 12
creator Comin, Camilla E.
Messerini, Luca
Novelli, Luca
Boddi, Vieri
Dini, Sergio
description We performed an immunohistochemical study with monoclonal antibodies to Ki-67 antigen and p53 protein on 45 cases of thymic epithelial tumors classified according to the recent World Health Organization (WHO) classification system to evaluate whether there is correlation between the expression of these markers and prognosis, histologic subtype, and myasthenia gravis (MG). We also correlated histologic subtype with sex, age, MG, and survival. Ki-67 and p53 labeling indices (LIs) were expressed as a percentage of positive nuclear immunostaining by counting 1,000 epithelial tumor cells. Statistically significant differences were found between Ki-67 LI and survival (p = 0.007), whereas the prognostic implication of p53 could not be demonstrated, although there appeared a trend that patients with tumors of higher LIs had worse survival. Significant correlations were also found between Ki-67 (p < 0.0005) and p53 (p < 0.0005) LIs and histologic subtypes. No correlation was found between these parameters and MG. Histologic subtypes of the WHO classification also correlated with survival (p = 0.01), whereas no correlation was found with sex, age, and MG. In conclusion, our results indicate that the proliferative activity, assessed by Ki-67 LI, and the histologic pattern, according to WHO classification system, seems to represent reliable parameters in the prognosis of thymic epithelial tumors.
doi_str_mv 10.1177/106689690401200412
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66990028</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_106689690401200412</sage_id><sourcerecordid>66990028</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-3cc5b3e120dc6afcde17f5b5d0c399d68c27904fbd15984eb84a4d32723c34523</originalsourceid><addsrcrecordid>eNp9kcFO3DAURa2KqlDaH-gCWSy6C9iO48RLNJoyqEhUYlCXkWO_zBglcbAdYL6A38ajGQkJJFb24rxjv3sR-kXJGaVleU6JEJUUknBCGSGcsi_oiEpOMsZFcZDuCci2xCH6HsI9IYQJRr-hQ1pwyStRHKGXv1eZKPHFEO0KBjx_Hj2EYN2A_3kwVseAbyf_aB9Vh9Vg8Mx5D52KEPCTjWu8sCG6zq2sTlwTNyNgO-C4Bvx_cYNnnUqy1moVt0rX4uV60yd2PqZh6GyyLqfe-fADfW1VF-Dn_jxGd3_my9kiu765vJpdXGc6FyJmudZFk0Na12ihWm2Alm3RFIboXEojKs3KlEfbGFrIikNTccVNzkqW65wXLD9Gv3fe0buHCUKsexs0dJ0awE2hFkLKFFOVwNN34L2b_JD-VjPKt3EzkSC2g7R3IXho69HbXvlNTUm97aj-2FEaOtmbp6YH8zayLyUB5zsgqBW8PfuJ8hXHVpn8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214200426</pqid></control><display><type>article</type><title>KI-67 Antigen Expression Predicts Survival and Correlates with Histologic Subtype in the WHO Classification of Thymic Epithelial Tumors</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Comin, Camilla E. ; Messerini, Luca ; Novelli, Luca ; Boddi, Vieri ; Dini, Sergio</creator><creatorcontrib>Comin, Camilla E. ; Messerini, Luca ; Novelli, Luca ; Boddi, Vieri ; Dini, Sergio</creatorcontrib><description>We performed an immunohistochemical study with monoclonal antibodies to Ki-67 antigen and p53 protein on 45 cases of thymic epithelial tumors classified according to the recent World Health Organization (WHO) classification system to evaluate whether there is correlation between the expression of these markers and prognosis, histologic subtype, and myasthenia gravis (MG). We also correlated histologic subtype with sex, age, MG, and survival. Ki-67 and p53 labeling indices (LIs) were expressed as a percentage of positive nuclear immunostaining by counting 1,000 epithelial tumor cells. Statistically significant differences were found between Ki-67 LI and survival (p = 0.007), whereas the prognostic implication of p53 could not be demonstrated, although there appeared a trend that patients with tumors of higher LIs had worse survival. Significant correlations were also found between Ki-67 (p &lt; 0.0005) and p53 (p &lt; 0.0005) LIs and histologic subtypes. No correlation was found between these parameters and MG. Histologic subtypes of the WHO classification also correlated with survival (p = 0.01), whereas no correlation was found with sex, age, and MG. In conclusion, our results indicate that the proliferative activity, assessed by Ki-67 LI, and the histologic pattern, according to WHO classification system, seems to represent reliable parameters in the prognosis of thymic epithelial tumors.</description><identifier>ISSN: 1066-8969</identifier><identifier>EISSN: 1940-2465</identifier><identifier>DOI: 10.1177/106689690401200412</identifier><identifier>PMID: 15494865</identifier><identifier>CODEN: IJSPFL</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adult ; Aged ; Biomarkers, Tumor - metabolism ; Carcinoma, Squamous Cell - classification ; Carcinoma, Squamous Cell - diagnosis ; Carcinoma, Squamous Cell - metabolism ; Carcinoma, Squamous Cell - mortality ; Cell Nucleus - metabolism ; Cell Nucleus - pathology ; Female ; Humans ; Immunohistochemistry ; Italy - epidemiology ; Ki-67 Antigen - metabolism ; Male ; Middle Aged ; Prognosis ; Survival Rate ; Thymoma - classification ; Thymoma - diagnosis ; Thymoma - metabolism ; Thymoma - mortality ; Thymus Neoplasms - classification ; Thymus Neoplasms - diagnosis ; Thymus Neoplasms - metabolism ; Thymus Neoplasms - mortality ; Tumor Suppressor Protein p53 - metabolism</subject><ispartof>International journal of surgical pathology, 2004-10, Vol.12 (4), p.395-400</ispartof><rights>Copyright Westminster Publications, Inc. Oct 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-3cc5b3e120dc6afcde17f5b5d0c399d68c27904fbd15984eb84a4d32723c34523</citedby><cites>FETCH-LOGICAL-c366t-3cc5b3e120dc6afcde17f5b5d0c399d68c27904fbd15984eb84a4d32723c34523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/106689690401200412$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/106689690401200412$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,778,782,21806,27911,27912,43608,43609</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15494865$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Comin, Camilla E.</creatorcontrib><creatorcontrib>Messerini, Luca</creatorcontrib><creatorcontrib>Novelli, Luca</creatorcontrib><creatorcontrib>Boddi, Vieri</creatorcontrib><creatorcontrib>Dini, Sergio</creatorcontrib><title>KI-67 Antigen Expression Predicts Survival and Correlates with Histologic Subtype in the WHO Classification of Thymic Epithelial Tumors</title><title>International journal of surgical pathology</title><addtitle>Int J Surg Pathol</addtitle><description>We performed an immunohistochemical study with monoclonal antibodies to Ki-67 antigen and p53 protein on 45 cases of thymic epithelial tumors classified according to the recent World Health Organization (WHO) classification system to evaluate whether there is correlation between the expression of these markers and prognosis, histologic subtype, and myasthenia gravis (MG). We also correlated histologic subtype with sex, age, MG, and survival. Ki-67 and p53 labeling indices (LIs) were expressed as a percentage of positive nuclear immunostaining by counting 1,000 epithelial tumor cells. Statistically significant differences were found between Ki-67 LI and survival (p = 0.007), whereas the prognostic implication of p53 could not be demonstrated, although there appeared a trend that patients with tumors of higher LIs had worse survival. Significant correlations were also found between Ki-67 (p &lt; 0.0005) and p53 (p &lt; 0.0005) LIs and histologic subtypes. No correlation was found between these parameters and MG. Histologic subtypes of the WHO classification also correlated with survival (p = 0.01), whereas no correlation was found with sex, age, and MG. In conclusion, our results indicate that the proliferative activity, assessed by Ki-67 LI, and the histologic pattern, according to WHO classification system, seems to represent reliable parameters in the prognosis of thymic epithelial tumors.</description><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Carcinoma, Squamous Cell - classification</subject><subject>Carcinoma, Squamous Cell - diagnosis</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Cell Nucleus - metabolism</subject><subject>Cell Nucleus - pathology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Italy - epidemiology</subject><subject>Ki-67 Antigen - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Survival Rate</subject><subject>Thymoma - classification</subject><subject>Thymoma - diagnosis</subject><subject>Thymoma - metabolism</subject><subject>Thymoma - mortality</subject><subject>Thymus Neoplasms - classification</subject><subject>Thymus Neoplasms - diagnosis</subject><subject>Thymus Neoplasms - metabolism</subject><subject>Thymus Neoplasms - mortality</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><issn>1066-8969</issn><issn>1940-2465</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kcFO3DAURa2KqlDaH-gCWSy6C9iO48RLNJoyqEhUYlCXkWO_zBglcbAdYL6A38ajGQkJJFb24rxjv3sR-kXJGaVleU6JEJUUknBCGSGcsi_oiEpOMsZFcZDuCci2xCH6HsI9IYQJRr-hQ1pwyStRHKGXv1eZKPHFEO0KBjx_Hj2EYN2A_3kwVseAbyf_aB9Vh9Vg8Mx5D52KEPCTjWu8sCG6zq2sTlwTNyNgO-C4Bvx_cYNnnUqy1moVt0rX4uV60yd2PqZh6GyyLqfe-fADfW1VF-Dn_jxGd3_my9kiu765vJpdXGc6FyJmudZFk0Na12ihWm2Alm3RFIboXEojKs3KlEfbGFrIikNTccVNzkqW65wXLD9Gv3fe0buHCUKsexs0dJ0awE2hFkLKFFOVwNN34L2b_JD-VjPKt3EzkSC2g7R3IXho69HbXvlNTUm97aj-2FEaOtmbp6YH8zayLyUB5zsgqBW8PfuJ8hXHVpn8</recordid><startdate>200410</startdate><enddate>200410</enddate><creator>Comin, Camilla E.</creator><creator>Messerini, Luca</creator><creator>Novelli, Luca</creator><creator>Boddi, Vieri</creator><creator>Dini, Sergio</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200410</creationdate><title>KI-67 Antigen Expression Predicts Survival and Correlates with Histologic Subtype in the WHO Classification of Thymic Epithelial Tumors</title><author>Comin, Camilla E. ; Messerini, Luca ; Novelli, Luca ; Boddi, Vieri ; Dini, Sergio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-3cc5b3e120dc6afcde17f5b5d0c399d68c27904fbd15984eb84a4d32723c34523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Carcinoma, Squamous Cell - classification</topic><topic>Carcinoma, Squamous Cell - diagnosis</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Cell Nucleus - metabolism</topic><topic>Cell Nucleus - pathology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Italy - epidemiology</topic><topic>Ki-67 Antigen - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Survival Rate</topic><topic>Thymoma - classification</topic><topic>Thymoma - diagnosis</topic><topic>Thymoma - metabolism</topic><topic>Thymoma - mortality</topic><topic>Thymus Neoplasms - classification</topic><topic>Thymus Neoplasms - diagnosis</topic><topic>Thymus Neoplasms - metabolism</topic><topic>Thymus Neoplasms - mortality</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Comin, Camilla E.</creatorcontrib><creatorcontrib>Messerini, Luca</creatorcontrib><creatorcontrib>Novelli, Luca</creatorcontrib><creatorcontrib>Boddi, Vieri</creatorcontrib><creatorcontrib>Dini, Sergio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of surgical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Comin, Camilla E.</au><au>Messerini, Luca</au><au>Novelli, Luca</au><au>Boddi, Vieri</au><au>Dini, Sergio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>KI-67 Antigen Expression Predicts Survival and Correlates with Histologic Subtype in the WHO Classification of Thymic Epithelial Tumors</atitle><jtitle>International journal of surgical pathology</jtitle><addtitle>Int J Surg Pathol</addtitle><date>2004-10</date><risdate>2004</risdate><volume>12</volume><issue>4</issue><spage>395</spage><epage>400</epage><pages>395-400</pages><issn>1066-8969</issn><eissn>1940-2465</eissn><coden>IJSPFL</coden><abstract>We performed an immunohistochemical study with monoclonal antibodies to Ki-67 antigen and p53 protein on 45 cases of thymic epithelial tumors classified according to the recent World Health Organization (WHO) classification system to evaluate whether there is correlation between the expression of these markers and prognosis, histologic subtype, and myasthenia gravis (MG). We also correlated histologic subtype with sex, age, MG, and survival. Ki-67 and p53 labeling indices (LIs) were expressed as a percentage of positive nuclear immunostaining by counting 1,000 epithelial tumor cells. Statistically significant differences were found between Ki-67 LI and survival (p = 0.007), whereas the prognostic implication of p53 could not be demonstrated, although there appeared a trend that patients with tumors of higher LIs had worse survival. Significant correlations were also found between Ki-67 (p &lt; 0.0005) and p53 (p &lt; 0.0005) LIs and histologic subtypes. No correlation was found between these parameters and MG. Histologic subtypes of the WHO classification also correlated with survival (p = 0.01), whereas no correlation was found with sex, age, and MG. In conclusion, our results indicate that the proliferative activity, assessed by Ki-67 LI, and the histologic pattern, according to WHO classification system, seems to represent reliable parameters in the prognosis of thymic epithelial tumors.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>15494865</pmid><doi>10.1177/106689690401200412</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1066-8969
ispartof International journal of surgical pathology, 2004-10, Vol.12 (4), p.395-400
issn 1066-8969
1940-2465
language eng
recordid cdi_proquest_miscellaneous_66990028
source MEDLINE; SAGE Complete A-Z List
subjects Adult
Aged
Biomarkers, Tumor - metabolism
Carcinoma, Squamous Cell - classification
Carcinoma, Squamous Cell - diagnosis
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - mortality
Cell Nucleus - metabolism
Cell Nucleus - pathology
Female
Humans
Immunohistochemistry
Italy - epidemiology
Ki-67 Antigen - metabolism
Male
Middle Aged
Prognosis
Survival Rate
Thymoma - classification
Thymoma - diagnosis
Thymoma - metabolism
Thymoma - mortality
Thymus Neoplasms - classification
Thymus Neoplasms - diagnosis
Thymus Neoplasms - metabolism
Thymus Neoplasms - mortality
Tumor Suppressor Protein p53 - metabolism
title KI-67 Antigen Expression Predicts Survival and Correlates with Histologic Subtype in the WHO Classification of Thymic Epithelial Tumors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T00%3A35%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=KI-67%20Antigen%20Expression%20Predicts%20Survival%20and%20Correlates%20with%20Histologic%20Subtype%20in%20the%20WHO%20Classification%20of%20Thymic%20Epithelial%20Tumors&rft.jtitle=International%20journal%20of%20surgical%20pathology&rft.au=Comin,%20Camilla%20E.&rft.date=2004-10&rft.volume=12&rft.issue=4&rft.spage=395&rft.epage=400&rft.pages=395-400&rft.issn=1066-8969&rft.eissn=1940-2465&rft.coden=IJSPFL&rft_id=info:doi/10.1177/106689690401200412&rft_dat=%3Cproquest_cross%3E66990028%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214200426&rft_id=info:pmid/15494865&rft_sage_id=10.1177_106689690401200412&rfr_iscdi=true